Annexure
| Names | Opening number on 1 July 2019 |
Granted during 2020 |
Forfeited/ lapsed during 2020 |
Settled/ exercised during 2020 |
Closing number on 30 June 2020 |
Cash value on settlement during 2020 |
Closing fair value at 30 June 2020 |
Strike price R |
| LP Ralphs | ||||||||
| Conditional Share Plan | ||||||||
| 11/12/2015 | 94 280 | – | 8 073 | 62 637 | 20 879 | 12 777 948 | 3 129 137 | |
| 24/10/2016 | 80 000 | – | 6 850 | 53 150 | 17 717 | 10 842 600 | 2 655 187 | |
| 27/11/2017 | 112 000 | – | – | – | 112 000 | – | 8 202 828 | |
| 03/12/2018 | 120 000 | – | – | – | 120 000 | – | 8 456 715 | |
| 28/11/2019 | – | 150 000 | – | – | 150 000 | – | 10 425 684 | |
| Total | 406 280 | 150 000 | 14 923 | 115 787 | 420 596 | 23 620 548 | 32 869 551 | |
| NT Madisa | ||||||||
| Conditional Share Plan | ||||||||
| 24/10/2016 | 20 000 | – | 1 713 | 13 287 | 4 429 | 2 710 548 | 663 797 | |
| 27/11/2017 | 30 000 | – | – | – | 30 000 | – | 2 197 186 | |
| 03/12/2018 | 40 000 | – | – | – | 40 000 | – | 2 818 905 | |
| 28/11/2019 | – | 75 000 | – | – | 75 000 | – | 5 212 842 | |
| 27/11/2020 | ||||||||
| Replacement rights (Options) | ||||||||
| 13/03/2014 | 6 250 | – | – | – | 6 250 | – | 1 166 485 | 238 |
| 03/11/2014 | 10 767 | – | – | 10 767 | – | 2 886 057 | – | 270 |
| 11/12/2015 | 20 000 | – | – | – | 20 000 | – | 2 452 753 | 302 |
| Total | 127 017 | 75 000 | 1 713 | 24 054 | 175 679 | 5 596 605 | 14 511 968 | |
| GC McMahon | ||||||||
| Conditional Share Plan | ||||||||
| 24/10/2016 | 12 000 | – | 1 028 | 7 972 | 2 658 | 1 626 288 | 398 278 | |
| 27/11/2017 | 15 000 | – | – | – | 15 000 | – | 1 098 593 | |
| 03/12/2018 | 30 000 | – | – | – | 30 000 | – | 2 114 179 | |
| 28/11/2019 | – | 50 000 | – | – | 50 000 | – | 3 475 228 | |
| 27/11/2019 | ||||||||
| Replacement rights (Options) | ||||||||
| 09/10/2014 | 5 000 | – | – | – | 5 000 | – | – | 251 |
| 11/12/2015 | 15 000 | – | – | – | 15 000 | – | – | 302 |
| Total | 77 000 | 50 000 | 1 028 | 7 972 | 117 658 | 1 626 288 | 9 793 081 | |
| MJ Steyn | ||||||||
| Conditional Share Plan | ||||||||
| 03/12/2018 | 40 000 | – | – | – | 40 000 | – | 2 818 905 | |
| 28/11/2019 | – | 60 000 | – | – | 60 000 | – | 4 170 274 | |
| 27/11/2020 | ||||||||
| SARS | ||||||||
| 07/11/2016 | 40 000 | – | – | – | 40 000 | – | 339 770 | 147 |
| 09/11/2017 | 40 000 | – | – | – | 40 000 | – | 467 542 | 159 |
| Replacement rights (Options) | ||||||||
| 09/10/2014 | 3 750 | – | – | – | 3 750 | – | 650 429 | 251 |
| 11/12/2015 | 7 500 | – | – | – | 7 500 | – | 919 782 | 302 |
| Total | 131 250 | 60 000 | – | – | 191 250 | – | 9 366 702 | |
| Names | Granted during 2021 |
Forfeited/ lapsed during 2021 |
Settled/ exercised during 2021 |
Closing number on 30 June 2021 |
Cash value on settlement during 2021 |
Closing fair value at 30 June 2021 |
Strike price R |
| LP Ralphs | |||||||
| Conditional Share Plan | |||||||
| 11/12/2015 | – | – | 20 879 | – | 2 932 038 | – | |
| 24/10/2016 | – | – | 17 717 | – | 2 487 998 | – | |
| 27/11/2017 | – | 56 736 | 41 448 | 13 816 | 5 820 543 | 2 631 399 | |
| 03/12/2018 | – | 68 157 | – | 51 843 | – | 13 061 766 | |
| 28/11/2019 | – | 150 000 | – | – | – | – | |
| Total | – | 274 893 | 80 044 | 65 659 | 11 240 579 | 15 693 164 | |
| NT Madisa | |||||||
| Conditional Share Plan | |||||||
| 24/10/2016 | – | – | 4 429 | – | 622 105 | – | |
| 27/11/2017 | – | 15 197 | 11 102 | 3 701 | 1 559 054 | 704 839 | |
| 03/12/2018 | – | – | – | 40 000 | – | 4 353 922 | |
| 28/11/2019 | – | – | – | 75 000 | 7 960 769 | ||
| 27/11/2020 | 134 000 | – | – | 134 000 | 22 059 099 | ||
| Replacement rights (Options) | |||||||
| 13/03/2014 | – | – | – | 6 250 | – | 1 648 872 | 238 |
| 03/11/2014 | – | – | – | – | – | – | 270 |
| 11/12/2015 | – | – | – | 20 000 | – | 3 996 390 | 302 |
| Total | 134 000 | 15 197 | 15 531 | 278 951 | 2 181 159 | 40 723 889 | |
| GC McMahon | |||||||
| Conditional Share Plan | |||||||
| 24/10/2016 | – | – | 2 658 | – | 373 263 | – | |
| 27/11/2017 | – | 7 600 | 5 550 | 1 850 | 779 387 | 352 419 | |
| 03/12/2018 | – | – | – | 30 000 | – | 3 265 441 | |
| 28/11/2019 | – | – | – | 50 000 | – | 5 307 179 | |
| 27/11/2019 | 46 000 | – | – | 46 000 | – | 7 572 526 | |
| Replacement rights (Options) | |||||||
| 09/10/2014 | – | – | – | 5 000 | 1 253 147 | 251 | |
| 11/12/2015 | – | – | – | 15 000 | 2 997 292 | 302 | |
| Total | 46 000 | 7 600 | 8 208 | 147 850 | 1 152 649 | 20 748 006 | |
| MJ Steyn | |||||||
| Conditional Share Plan | |||||||
| 03/12/2018 | – | – | – | 40 000 | – | 4 353 922 | |
| 28/11/2019 | – | – | – | 60 000 | – | 6 368 615 | |
| 27/11/2020 | 57 000 | – | – | 57 000 | – | 9 383 348 | |
| SARS | |||||||
| 07/11/2016 | – | – | – | 40 000 | – | 1 846 070 | 147 |
| 09/11/2017 | – | – | – | 40 000 | – | 1 520 277 | 159 |
| Replacement rights (Options) | |||||||
| 09/10/2014 | – | – | – | 3 750 | – | 939 861 | 251 |
| 11/12/2015 | – | – | – | 7 500 | – | 1 498 646 | 302 |
| Total | 57 000 | – | – | 248 250 | – | 25 910 739 |
Type of award
| Valuation methodology applied | ||||
| Award date | Tranche* | Market value estimation using a market valuation technique |
Intrinsic value** |
|
| Conditional share | 27/11/2017 | n/a | √ | |
| Conditional share | 03/12/2018 | n/a | √ | √ |
| Conditional share | 28/11/2019 | n/a | √ | |
| Conditional share | 28/11/2020 | n/a | √ | |
| Replacement share | 13/03/2014 | 3 | √ | |
| Replacement share | 09/10/2014 | 2 and 3 | √ | |
| Replacement share | 03/11/2014 | 3 | √ | |
| Replacement share | 11/12/2015 | 2 | √ | |
| Replacement share | 11/12/2015 | 3 | √ | |
| SARS | 07/11/2016 | 1 and 2 | √ | |
| SARS | 07/11/2016 | 3 | √ | |
| SARS | 09/11/2017 | 1 and 2 | √ | |
| SARS | 09/11/2017 | 3 | √ |
| Bidvest 20-day Vwap |
Bidcorp 20-day Vwap |
Bidvest 20-day Vwap |
Bidcorp 20-day Vwap |
Strike price |
Performance conditions vesting % |
Performance conditions |
Vesting date | ||
| Conditional share | 193.54 | n/a | 149.87 | n/a | n/a | 49% | √ | 25% – 30/09/2021 | |
| Conditional share | 193.54 | n/a | 149.87 | n/a | n/a | 58% | √ | 75% – 30/09/2021 |
|
| 25% – 30/09/2022 | |||||||||
| Conditional share | 193.54 | n/a | 149.87 | n/a | n/a | 58% | √ | 75% – 30/09/2022 |
|
| 25% – 30/09/2023 | |||||||||
| Conditional share | 193.54 | n/a | 149.87 | n/a | n/a | 93% | √ | 75% – 30/09/2023 |
|
| 25% – 30/09/2024 | |||||||||
| Replacement share | 193.54 | 307.82 | 149.87 | 274.31 | 237.54 | n/a | x | 25% – 13/03/2019 | |
| Replacement share | 193.54 | 307.82 | 149.87 | 274.31 | 250.73 | n/a | x | 25% – 09/10/2018 |
|
| 25% – 09/10/2019 | |||||||||
| Replacement share | 193.54 | 307.82 | 149.87 | 274.31 | 269.95 | n/a | x | 25% – 03/11/2019 | |
| Replacement share | 193.54 | 307.82 | 149.87 | 274.31 | 301.54 | n/a | x | 25% – 11/12/2019 | |
| Replacement share | 193.54 | 307.82 | 149.87 | 274.31 | 301.54 | n/a | x | 25% – 11/12/2020 | |
| SARS | 193.54 | n/a | 149.87 | n/a | 146.61 | n/a | x | 50% – 07/11/2019 |
|
| 25% – 07/11/2020 | |||||||||
| SARS | 193.54 | n/a | 149.87 | n/a | 146.61 | n/a | x | 25% – 07/11/2021 | |
| SARS | 193.54 | n/a | 149.87 | n/a | 158.75 | n/a | x | 50% – 09/11/2020 |
|
| 25% – 09/11/2021 | |||||||||
| SARS | 193.54 | n/a | 149.87 | n/a | 158.75 | n/a | x | 25% – 09/11/2022 |
| * | Where a tranche has not been included, the awards were already exercised. |
| ** | Intrinsic value less present value of September 2021 dividend which the instrument is not entitled to in respect of awards not yet vested. |